This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN advanced 7.44% to $2.60 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.16% to 3,831.39 and the Dow Jones Industrial Average DJIA falling 0.42% to 30,967.82. This was the stock's fourth consecutive day of gains. Ocugen Inc. closed $15.05 below its 52-week high ($17.65), which the company reached on November 3rd.
The stock outperformed some of its competitors Tuesday, as Adverum Biotechnologies Inc. ADVM fell 1.69% to $1.16, Ocular Therapeutix Inc. OCUL rose 6.11% to $4.34, and Kodiak Sciences Inc. KOD rose 3.61% to $8.03. Trading volume (7.3 M) eclipsed its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 5, 2022.
(END) Dow Jones Newswires
July 05, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.